Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. All News
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about ASTELLAS PHARMA INC.
09/09ASTELLAS PHARMA : Updates “Contact for Potential Acquisition of ' R&D Prog..
PU
09/02ASTELLAS PHARMA : Nitto, and M. Heart Partnering for ECG testing service
PU
09/01Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X..
CI
08/31ASTELLAS PHARMA : Announces Personnel Changes
PU
08/30ASTELLAS PHARMA : Launches its Corporate Website's New Modalities~Approac..
PU
08/20SECTOR UPDATE : Health Care Stocks Mixed Premarket Friday
MT
08/20FIBROGEN : Receives $120 Million Milestone Payment With Approval of Evrenzo in E..
MT
08/20ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVREN..
PU
08/19ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVREN..
AQ
08/19ASTELLAS PHARMA : Receives EC Approval for First-inClass EVRENZO (roxadustat) fo..
PU
08/19Astellas Receives EC Approval for First-Inclass Evrenzo for Adult Patients wi..
CI
08/18Nikkei snaps 4-day losing streak, but Delta worries persist
RE
08/17Japanese shares bounce back as defensive stocks gain
RE
08/17PRESS RELEASE : Basilea reports strong financial results for half-year 2021 with..
DJ
08/11FDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney Disease
DJ
08/06ASTELLAS PHARMA : Reforms Research Organization
PU
08/05Modalis Announces Completion of a Research Collaboration on Angelman Syndrome..
CI
07/30ASTELLAS PHARMA : and Minovia Therapeutics Announce Strategic Collaboration for ..
BU
07/30Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel ..
CI
07/30Astellas Pharma Inc. Revises Earnings Guidance for the Full Year 2022
CI
07/30Astellas Pharma Inc. Reports Earnings Results for the First Quarter Ended Jun..
CI
07/29ASTELLAS PHARMA : Financial Results (Q1/FY2021)
PU
07/29ASTELLAS PHARMA : Presentation Material for Information Meeting (Q1/FY2021)
PU
07/29ASTELLAS PHARMA : Supplementary Documents (Q1/FY2021)
PU
07/20The U.S. Food and Drug Administration Approves Astellas Pharma Inc.'s Supplem..
CI
07/15Piers Morgan Joins Pharnext's Board of Directors
DJ
07/15Piers Morgan rejoint le Conseil d'Administration de Pharnext
DJ
07/13ExCellThera and Astellas Enters into a License for the Use of Molecule UM171 ..
CI
07/12Affinivax and Astellas Presents Safety and Immunogenicity Data from Phase 2 S..
CI
07/12ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA..
AQ
07/11ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA..
PU
07/09ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA..
BU
06/29ASTELLAS PHARMA : Corporate Governance Report
PU
06/28ASTELLAS PHARMA : Receives Positive CHMP Opinion for EVRENZO (roxadustat) for Ad..
PU
06/25FIBROGEN : Gets Positive Opinion From European Panel for Roxadustat in Patients ..
MT
06/25Astellas Receives Positive CHMP Opinion for Evrenzo™ for Adult Patients with ..
CI
06/24PFIZER : First participant dosed in pfizer's pivotal phase 3 talapro-3 combinati..
AQ
06/21Astellas Pharma to Incur Nearly $196 Million Impairment Loss From Termination..
MT
06/17ASTELLAS PHARMA : Notice Regarding Impairment Loss Following the Termination of ..
PU
06/16ASTELLAS PHARMA : Transfers Five Legacy Products in Europe, Russia, CIS and Asia..
PU
06/09ASTELLAS PHARMA : New Research Reflects Astellas' Commitment to Acute Myeloid Le..
AQ
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/02ASTELLAS PHARMA : Reviewing capabilities for sustainable growth - Astellas Will ..
PU
06/02PRESS RELEASE : MorphoSys to Acquire Constellation -2-
DJ
05/31Japanese shares end lower on profit-booking, drugmakers limit losses
RE
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/26Japanese shares fall on profit-taking, pandemic worries
RE
05/20ASTELLAS PHARMA : and Seagen Announce Updated Results from Two Trials of PADCEV ..
AQ
05/19ASTELLAS PHARMA : Seagen and Astellas Announce Updated Results from Two Trials o..
BU
05/18Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS..
AQ
05/14Japan's Ministry of Health, Labour and Welfare Grants Astellas Pharma Inc. Pr..
CI
05/12ASTELLAS PHARMA : Notice Regarding Continuation of the Performance-linked Stock ..
PU
05/11PRESS RELEASE : AMSilk raises EUR 29M to accelerate commercialization of its hig..
DJ
05/11PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r..
DJ
05/11Autobahn Therapeutics, Inc. acquired global rights to ASP3652 from Astellas P..
CI
05/06ASTELLAS PHARMA : ' XTANDI (enzalutamide) Approved by European Commission for Me..
PU
05/05ASTELLAS PHARMA : ' XTANDI (enzalutamide) Approved by European Commission for Me..
AQ
05/04Astellas' XTANDI™ (enzalutamide) Approved by European Commission for Men with..
CI
04/30Astellas Pharma Inc. Terminates License and Collaboration Agreement with Cyto..
CI
04/28ASTELLAS PHARMA INC. : - Notice Regarding Impairment Loss for Investigational Ge..
AQ
04/28ASTELLAS PHARMA INC. : - Change of Directors
AQ
04/27PRESS RELEASE : MIG AG records 2020 as the most successful year in its company h..
DJ
04/27ASTELLAS PHARMA : Change of Directors
PU
04/27Astellas Pharma Inc. Announces Keiko Yamagami to Resign as Director
CI
04/26ASTELLAS PHARMA : Notice Regarding Impairment Loss for Investigational Gene Ther..
PU
04/26Astellas Pharma Inc. Reports Earnings Results for the Year Ended March 31, 20..
CI
04/22Zenith Epigenetics Announces Clinical Collaboration with Astellas
CI
04/20ASTELLAS PHARMA : and Seagen Announce U.S. FDA Acceptance of Two Supplemental Bi..
AQ
04/20ASTELLAS PHARMA : and Seagen Announce FDA Acceptance of Two Supplemental Biologi..
PU
04/19SEAGEN : Astellas' Biologics License Applications for Bladder Cancer Drug Candid..
MT
04/14SHANGHAI STOCK EXCHANGE B SHARES IND : China Opens Innovative Medicines, Medical..
MT
04/13ASTELLAS PHARMA : Updates 'Contact for Potential Acquisition of ' R&D Programs' ..
AQ
04/07PRESS RELEASE : T-knife Therapeutics Announces the Appointment of Donald Wuchter..
DJ
04/04ASTELLAS PHARMA : and TOA EIYO Announce Termination of Distribution Agreement
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTELLAS PHARMA INC.
09/26/21